UAB MedCast

Guidelines for Pap Smear Screenings for Cervical Cancer

Warner Huh, MD - Speaker Bio
Warner Huh, MD is Professor and Director of the Division of Gynecologic Oncology, his areas of expertise include Gynecologic oncology, cancer vaccine, robotic surgery for gyn/onc, ovarian cancer, endometrial cancer.

Learn more about Warner Huh, MD 

Dr. Huh has the following financial relationships with commercial interests:

Merck - Consulting Fee

Dr. Huh does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships to disclose.

There is no commercial support for this activity.
  • Topic Info:About 80 million U.S. women ages 25 to 65 — or 1.2 million women across Alabama — should be screened periodically by their health care providers for cervical cancer.

    At present, the standard way to do that is a Pap smear alone, or co-testing using both a Pap smear and a human papillomavirus (HPV) test. Under the new guidance, the Pap smear, which dates back more than 80 years, would still be used for follow-up tests if an HPV test is positive. The Pap smear will still be used for primary screening of women under age 25.

    At the UAB Medicine Women's Cancer Program, we use the most advanced facilities from board-certified gynecologic oncologists trained in surgery, chemotherapy, and radiation. Our experts design customized treatment plans for each patient's individual needs and use the latest technology to screen for and treat all types of women's reproductive cancers.

    Listen in as Warner Huh, MD discusses the latest guidelines for Pap Smear Screenings for Cervical Cancer.